-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-NRx Pharmaceuticals (NasdaqNrxp) Announces FDA Clearance To Proceed With Clinical Trial Of Nrx-101 In Combination With Robotic-Enabled Transcranial Magnetic Stimulation In Patients With Depression And Suicidality

Reuters·05/07/2026 12:11:41

Please log in to view news